Severe Chronic Pain - Remoxy(TM) (ORADUR-based Oxycodone) Receives Special Protocol Assessment And Commences Pivotal Phase III

... Durect Corporation(Nasdaq: DRRX) reported today that Remoxy(TM), an abuse-resistant painmedicine under development based on DURECT''s patented ORADUR(TM) technologyincorporating the opioid oxycodone has successfully completed a SpecialProtocol Assessment with the U.S. Food and Drug Administration (FDA) and thata pivotal Phase III trial is being commenced on Remoxy in 400 patients withsevere chronic pain... click link for more info. ...